These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39081128)

  • 21. The APOE4 effect: structural brain differences in Alzheimer's disease according to the age at symptom onset.
    Forno G; Contador J; Pérez-Millan A; Guillen N; Falgàs N; Sarto J; Tort-Merino A; Castellví M; Bosch B; Fernández-Villullas G; Balasa M; Antonell A; Sala-Llonch R; Sanchez-Valle R; Hornberger M; Lladó A
    Eur J Neurol; 2023 Mar; 30(3):597-605. PubMed ID: 36463489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered small-world anatomical networks in Apolipoprotein-E4 (ApoE4) carriers using MRI.
    Goryawala M; Zhou Q; Duara R; Loewenstein D; Cabrerizo M; Barker W; Adjouadi M
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():2468-71. PubMed ID: 25570490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism.
    Nielsen HM; Chen K; Lee W; Chen Y; Bauer RJ; Reiman E; Caselli R; Bu G
    Alzheimers Res Ther; 2017 Jan; 9(1):5. PubMed ID: 28137305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of APOE ε4 with cerebral gray matter volumes in non-demented older adults: The MEMENTO cohort study.
    Régy M; Dugravot A; Sabia S; Fayosse A; Mangin JF; Chupin M; Fischer C; Bouteloup V; Dufouil C; Chêne G; Paquet C; Hanseeuw B; Singh-Manoux A; Dumurgier J;
    Neuroimage; 2022 Apr; 250():118966. PubMed ID: 35122970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal changes in
    Luckett ES; Schaeverbeke J; De Meyer S; Adamczuk K; Van Laere K; Dupont P; Vandenberghe R
    Neuroimage Clin; 2023; 37():103321. PubMed ID: 36621019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between APOE Genotype and Structural MRI Measures throughout Adulthood in the Study of Health in Pomerania Population-Based Cohort.
    Habes M; Toledo JB; Resnick SM; Doshi J; Van der Auwera S; Erus G; Janowitz D; Hegenscheid K; Homuth G; Völzke H; Hoffmann W; Grabe HJ; Davatzikos C
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1636-42. PubMed ID: 27173368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.
    Fleisher AS; Chen K; Liu X; Ayutyanont N; Roontiva A; Thiyyagura P; Protas H; Joshi AD; Sabbagh M; Sadowsky CH; Sperling RA; Clark CM; Mintun MA; Pontecorvo MJ; Coleman RE; Doraiswamy PM; Johnson KA; Carpenter AP; Skovronsky DM; Reiman EM
    Neurobiol Aging; 2013 Jan; 34(1):1-12. PubMed ID: 22633529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study.
    Low A; Prats-Sedano MA; McKiernan E; Carter SF; Stefaniak JD; Nannoni S; Su L; Dounavi ME; Muniz-Terrera G; Ritchie K; Lawlor B; Naci L; Malhotra P; Mackay C; Koychev I; Ritchie CW; Markus HS; O'Brien JT
    Alzheimers Res Ther; 2022 Oct; 14(1):154. PubMed ID: 36224605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study.
    O'Dwyer L; Lamberton F; Matura S; Tanner C; Scheibe M; Miller J; Rujescu D; Prvulovic D; Hampel H
    PLoS One; 2012; 7(11):e48895. PubMed ID: 23152815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proximity to dementia onset and multi-modal neuroimaging changes: The prevent-dementia study.
    Mak E; Dounavi ME; Low A; Carter SF; McKiernan E; Williams GB; Jones PS; Carriere I; Muniz GT; Ritchie K; Ritchie C; Su L; O'Brien JT
    Neuroimage; 2021 Apr; 229():117749. PubMed ID: 33454416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large intracranial volume accelerates conversion to dementia in males and APOE4 non-carriers with mild cognitive impairment.
    An H; Son SJ; Cho S; Cho EY; Choi B; Kim SY;
    Int Psychogeriatr; 2016 May; 28(5):769-78. PubMed ID: 26674540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential association of cerebral blood flow and anisocytosis in APOE ε4 carriers at midlife.
    Dounavi ME; Mak E; Swann P; Low A; Muniz-Terrera G; McKeever A; Pope M; Williams GB; Wells K; Lawlor B; Naci L; Malhotra P; Mackay C; Koychev I; Ritchie K; Su L; Ritchie CW; O'Brien JT
    J Cereb Blood Flow Metab; 2023 Oct; 43(10):1672-1684. PubMed ID: 37132287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced rapid eye movement sleep in late middle-aged and older apolipoprotein E ɛ4 allele carriers.
    André C; Martineau-Dussault MÈ; Baril AA; Marchi NA; Daneault V; Lorrain D; Hudon C; Bastien CH; Petit D; Thompson C; Poirier J; Montplaisir J; Gosselin N; Carrier J
    Sleep; 2024 Jul; 47(7):. PubMed ID: 38634644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluid-attenuated inversion recovery magnetic resonance imaging textural features as sensitive markers of white matter damage in midlife adults.
    Dounavi ME; Low A; Muniz-Terrera G; Ritchie K; Ritchie CW; Su L; Markus HS; O'Brien JT
    Brain Commun; 2022; 4(3):fcac116. PubMed ID: 35611309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and resting-state MRI detects regional brain differences in young and mid-age healthy APOE-e4 carriers compared with non-APOE-e4 carriers.
    Dowell NG; Evans SL; Tofts PS; King SL; Tabet N; Rusted JM
    NMR Biomed; 2016 May; 29(5):614-24. PubMed ID: 26929040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.
    Morris JK; Uy RAZ; Vidoni ED; Wilkins HM; Archer AE; Thyfault JP; Miles JM; Burns JM
    J Alzheimers Dis; 2017; 58(4):1129-1135. PubMed ID: 28550261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Apolipoprotein E4 Polymorphism on the Gray Matter Volume and the White Matter Integrity in Subjective Memory Impairment without White Matter Hyperintensities: Voxel-Based Morphometry and Tract-Based Spatial Statistics Study under 3-Tesla MRI.
    Lee YM; Ha JK; Park JM; Lee BD; Moon E; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
    J Neuroimaging; 2016; 26(1):144-9. PubMed ID: 25678236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease.
    Hey JA; Abushakra S; Blennow K; Reiman EM; Hort J; Prins ND; Sheardova K; Kesslak P; Shen L; Zhu X; Albayrak A; Paul J; Schaefer JF; Power A; Tolar M
    Drugs; 2024 Jul; 84(7):811-823. PubMed ID: 38902571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.